MRCAT Prostate + Auto-Contouring
MR-RT clinical application
MRCAT Prostate + Auto-Contouring
MR-RT clinical application
As a plug-in clinical application to Ingenia MR-RT, MRCAT Prostate + Auto-Contouring provides attenuation maps and automated, MR-based contours of prostate and organs at risk in as little as 20 minutes – all in a repeatable ‘one-click’ workflow.
MR-sim and contouring in 20 minutes
Automatic generation of synthetic CT images
Accurate contours with little to no user interaction
Image gallery
- Consistent MR-based contouring
- MRCAT prostate + Auto-Contouring
- MRCAT generation
- MRCAT based Treatment Plan Pinnacle
Features
Drive speed, accuracy and consistency
Because MRCAT Prostate requires input from MR images only, it reduces the organization and coordination of scans, eliminates the effort involved in MR-CT registration, and saves the patient from undergoing multiple procedures. Moreover, Auto-Contouring automates standard, labor-intensive and repetitive tasks, while at the same time reducing variability and errors caused by manual steps. This improves consistency and reproducibility - for more confidence in the planning process.
Fast, consistent imaging protocol
A dedicated, standardized imaging protocol includes a T1W mDIXON XD and a T2W TSE scan as source data for the generation of MRCAT (MR for Calculating ATtenuation) density maps and MR-based Auto-Contouring. Compressed SENSE acceleration keeps the total scan time short, which promotes patient comfort by minimizing time in the scanner and helps to boost productivity.
Automatic generation of synthetic CT images
MRCAT Prostate automatically generates attenuation maps using the high-resolution mDIXON scan as source. Smart, validated algorithms enable automatic tissue segmentation and assignment of Hounsfield Units to deliver MRCAT images with CT-like density information for dose calculations - directly on the MR console.
Specifications
- MRCAT Prostate and Auto-Contouring
- Compatibility MR system
- Ingenia 1.5T and 3.0T MR-RT, Ambition 1.5T MR-RT and Elition 3.0T MR-RT
Recommended products
- The Philips Ingenia MR-RT XD platform harnesses the power and value of MRI for radiation therapy planning. It has been designed around the needs of radiation oncology, with ease-of-use, streamlined integration, and versatility in mind. Central to that concept is the ability to define a tailored approach with customizable functionality that meets your individual clinical, workflow, and budgetary requirements – all to provide better patient care.
- MRCAT Brain clinical application allows the use of MRI as the primary imaging modality for radiotherapy planning of primary and metastatic tumors in the brain without the need for CT. Detailed anatomical information for contouring and attenuation maps for dose calculations are both obtained from a single, submillimeter resolution 3D T1W mDIXON MR sequence. Artificial Intelligence (AI) is used for fast computation of continuous Hounsfield units directly on the MR console.
- MRCAT Pelvis lets you plan radiation therapy using MRI as a single modality solution. Within just one MR exam, MRCAT Pelvis provides excellent soft-tissue contrast for target and OAR delineation, and continuous Hounsfield units for dose calculations. MRCAT (MR for Calculating ATtenuation) data can be used for export to treatment planning systems for CT-equivalent** dose calculations. In addition, MR-based imaging enables CBCT-based positioning based on soft-tissue contrast with the look and feel of CT.
- MRCAT Head and Neck enables the use of MRI as a primary imaging modality for radiotherapy planning of patients with soft tissue tumors in the Head and Neck, without the need for CT. Powered by AI, MRCAT (MR for Calculating ATtenuation) images with CT-like density information are automatically generated from a single, high-resolution MR scan and can be used for CT-equivalent¹ dose calculations and accurate² patient positioning.
Disclaimer
*Accurate means: MRCAT provides < ± 1 mm total geometric accuracy of image data in < 20 cm Diameter Spherical Volume (DSV) and < ± 2 mm total geometric accuracy of image data in < 40 cm Diameter Spherical Volume (DSV))*. *Limited to 32 cm in z-direction in more than 95% of the points within the volume.
**The simulated dose based on MRCAT images does not differ in >95% of prostate cancer patients (Gamma analysis criterion 3%/3 mm realized in 99% of voxels exceeding 75% of the maximum dose) when compared with the CT-based plan for EBRT.
***Accurate means 95th percentile modified Hausdorff distance <5mm compared to contours made by experts manually. Average distance is <1.5 mm and is measured as average modified Hausdorff distance compared to contours made by experts manually.
**** Based on 49 cases (each for anatomical prostate, bladder, rectum, penile bulb and femur heads).